Comprehensive mutation analysis for congenital muscular dystrophy: a clinical PCR-based enrichment and next-generation sequencing panel.
about
Navigating the rapids: the development of regulated next-generation sequencing-based clinical trial assays and companion diagnosticsIdentification of a novel nemaline myopathy-causing mutation in the troponin T1 (TNNT1) gene: a case outside of the old order AmishClinQC: a tool for quality control and cleaning of Sanger and NGS data in clinical research.Disease-targeted sequencing of ion channel genes identifies de novo mutations in patients with non-familial Brugada syndromeDiagnostics of primary immunodeficiency diseases: a sequencing capture approachTarget enrichment using parallel nanoliter quantitative PCR amplification.Application of a target enrichment-based next-generation sequencing protocol for identification and sequence-based prediction of pneumococcal serotypesImplementation of Cloud based next generation sequencing data analysis in a clinical laboratory.Mung bean nuclease treatment increases capture specificity of microdroplet-PCR based targeted DNA enrichmentClinical Impact and Cost-Effectiveness of Whole Exome Sequencing as a Diagnostic Tool: A Pediatric Center's Experience.Targeted high throughput sequencing in hereditary ataxia and spastic paraplegiaThe effect of early, comprehensive genomic testing on clinical care in neonatal diabetes: an international cohort study.Expanding genotype/phenotype of neuromuscular diseases by comprehensive target capture/NGS.Disease-targeted sequencing: a cornerstone in the clinicComprehensive analysis to improve the validation rate for single nucleotide variants detected by next-generation sequencing.Diagnostic use of Massively Parallel Sequencing in Neuromuscular Diseases: Towards an Integrated Diagnosis.A systematic approach to assessing the clinical significance of genetic variants.Solving the molecular diagnostic testing conundrum for Mendelian disorders in the era of next-generation sequencing: single-gene, gene panel, or exome/genome sequencing.Genome-Wide Sequencing for Prenatal Detection of Fetal Single-Gene Disorders.Ethical issues in the evaluation of adults with suspected genetic neuromuscular disorders.Ullrich Congenital Muscular Dystrophy Possibly Related With COL6A1 p.Gly302Arg Variant.Target resequencing of neuromuscular disease-related genes using next-generation sequencing for patients with undiagnosed early-onset neuromuscular disorders.New splicing mutation in the choline kinase beta (CHKB) gene causing a muscular dystrophy detected by whole-exome sequencing.A comprehensive genomic approach for neuromuscular diseases gives a high diagnostic yield.Cryptic splice activation but not exon skipping is observed in minigene assays of dystrophin c.9361+1G>A mutation identified by NGS.LAMA2-related myopathy: Frequency among congenital and limb-girdle muscular dystrophies.Molecular diagnosis of Duchenne muscular dystrophy.Targeted Re-Sequencing Emulsion PCR Panel for Myopathies: Results in 94 Cases.Amelioration of Muscle and Nerve Pathology in LAMA2 Muscular Dystrophy by AAV9-Mini-Agrin.Deletion of exon 4 in LAMA2 is the most frequent mutation in Chinese patients with laminin α2-related muscular dystrophy
P2860
Q26864332-FE9D1C14-17E1-448F-AE39-A55D1883B1B9Q28252275-E0BCC2F2-A4C0-4392-BDFE-EE57ECF35970Q31041831-ED6A34E4-957F-4E22-A15F-41FD9D127C97Q33164900-BC6510CD-253B-47DB-8803-D11E6DFC2A9DQ34681895-D1DE4186-0C38-48E4-A82D-912091EAC46DQ35115643-0711FC52-2017-4FC6-8F1C-4B9BA62968C2Q35115669-47E3C5C7-A216-44C1-8EEF-5AE9E5A7F3BCQ35178920-0C18B355-433B-41FE-BA5D-56712787110DQ35212585-F3975856-8BBB-436E-8217-746ED7842ECDQ35910407-F5A2ADDE-42A4-47A7-B65D-43A46B334A3AQ36330076-261771A0-161D-4FCA-AB4E-FB066349DCF7Q36634562-7FE5116B-13BD-4240-80E5-F42C8A6575A8Q36729177-58EDF30F-D26C-410B-BD85-D300F475EA97Q37205397-E5AF26E8-18D3-4053-AD08-E44F42740E36Q37529440-E9CB8F3C-6D40-43F7-8399-B910799EB99CQ37589634-2783745A-7B47-4901-92EA-C8258B677FBFQ37715677-665181C8-A1AD-4006-9502-AE3C86CD59E2Q38252010-2C864F1F-BE66-4E3D-89CD-DE3F1448AA07Q38562550-01BFAF12-A51C-405C-8F9B-E3F3DA3E5FE5Q38951129-6AC8EFA0-DA67-473C-8BE3-0F38C645D017Q39755887-6601835F-5E85-47AC-9353-A1F2582FD5BBQ40675087-CC2EE593-756E-4F57-9D58-35B1C290BBCFQ41294079-2BD53B96-7C7A-4B54-9704-3D8C8A7037C7Q43754788-9500DC42-D1BE-4E48-9A5C-3A3448D6996AQ48017631-6241589E-489D-45EF-8494-A1DE70154FC6Q48338116-07BA83DD-0F62-4F0C-A4F5-85371E12C358Q51030653-759715B7-3500-49F0-A406-56FAA071EC05Q51063227-82B03F45-FEE7-4679-8189-E85BDBB8DEEDQ54210538-9B7971AA-7077-4BAA-8859-9022548439FAQ57292499-75340169-493F-4AF5-98F3-EA99DBEE793A
P2860
Comprehensive mutation analysis for congenital muscular dystrophy: a clinical PCR-based enrichment and next-generation sequencing panel.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Comprehensive mutation analysi ...... t-generation sequencing panel.
@ast
Comprehensive mutation analysi ...... t-generation sequencing panel.
@en
Comprehensive mutation analysi ...... t-generation sequencing panel.
@nl
type
label
Comprehensive mutation analysi ...... t-generation sequencing panel.
@ast
Comprehensive mutation analysi ...... t-generation sequencing panel.
@en
Comprehensive mutation analysi ...... t-generation sequencing panel.
@nl
prefLabel
Comprehensive mutation analysi ...... t-generation sequencing panel.
@ast
Comprehensive mutation analysi ...... t-generation sequencing panel.
@en
Comprehensive mutation analysi ...... t-generation sequencing panel.
@nl
P2093
P2860
P1433
P1476
Comprehensive mutation analysi ...... t-generation sequencing panel.
@en
P2093
Anne Rutkowski
C Alexander Valencia
Carsten Bonnemann
Devin Rhodenizer
Lisa Mari Keong
Madhuri Hegde
Martin Robert Littlejohn
Shruti Bhide
Susan Sparks
P2860
P304
P356
10.1371/JOURNAL.PONE.0053083
P407
P577
2013-01-11T00:00:00Z